Atalan

Private

United StatesHealthcare & Life Scienceshttps://www.atalantech.com/

Last Round

Seed

Oct 5, 2023

Est. Valuation

$5.5M

Total Funding Raised

$2.52M

Company Overview

Atalan is a healthcare technology company that provides a Clinician Retention Intelligence (CRI) platform, using machine learning to help health systems predict and prevent clinician resignations.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical asset managementmedical device managementclinical engineeringhealthcare asset trackingmedical equipment optimizationclinical operations softwarepredictive analyticshealthcare SaaSvertical SaaShospital inventory managementasset utilizationHTMhealthcare technology managementhospital opsmedtech analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atalan Comparables

Compare Atalan with similar companies based on industry and business-model similarity.

Atalan comparables — related companies by embedding similarity
Company	Similarity	Market Cap
symplr	53%
Hearst Communications	52%
Laudio	49%

View all Comparables

Atalan Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Oct 5, 2023
Accelerator	Aug 2, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Xi Hu

Chief Wellbeing Economist and Chief Product Officer, Co-Founder

Founding Team

Tiffany Chan

CEO And Co-Founder

Founding Team

Ram Prayaga

Chief Technology Officer

Executive Team

Atalan Investors

Notable investors and investment history

Atalan investors
Investor	Rounds
Early Light Ventures	Seed
Excelerate Health Ventures	Seed
XLerateHealth	Seed, Accelerator
OCA Ventures	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 1, 2026
New nursing-focused product set to launch in Q1 2026.
Dec 10, 2025
Launched Atalan PX, an AI module, with Accrete Health Partners.

View all signals

Atalan Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Atalan Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Atalan's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States

Employee Range24

Year Founded2022

Last FundingOct 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.